Clorox (CLX) 1Q16 EPS Beat Driven by Top-Line Growth; UBS Raises Price Target to $105
UBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $105.00 (from $103.00), following the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
